Monoclonal Antibodies In India

Monoclonal Antibodies In India | 2023

Monoclonal antibodies are laboratory-produced proteins that are designed to mimic the immune system's ability to fight off infections and diseases. They are made by cloning a single immune cell, resulting in an identical population of cells that all produce the same antibody. Monoclonal antibodies are used to treat a variety of conditions, including cancer, autoimmune disorders, and certain infections.

Monoclonal Antibodies In India are increasingly being used to treat a variety of medical conditions. One of the main advantages of monoclonal antibodies is their ability to target specific cells or proteins in the body, which makes them more selective and effective than traditional treatments. For example, they can be used to target and destroy cancer cells while leaving healthy cells unharmed.

There are several monoclonal antibodies that have been approved for use in India, including rituximab, trastuzumab, and adalimumab. These drugs are used to treat conditions such as leukemia, breast cancer, and rheumatoid arthritis, respectively. For more detail information about Monoclonal Antibodies India, visit Genextgenomics.

Comments

Impact of CDR Length on Antibody Functionality

Image by freepik Antibodies rely on their complementarity-determining regions (CDRs) to recognize and bind antigens with high specificity. Among these regions, CDR3-particularly in the heavy chain (CDR-H3)-exhibits remarkable length diversity, directly influencing antigen recognition, structural stability, and therapeutic efficacy. Understanding how CDR length shapes antibody functionality is critical for advancing biologics, diagnostics, and immunotherapy . The Role of CDR-H3 in Antibody Diversity CDR-H3 is the most variable region in antibodies, formed by the recombination of V, D, and J gene segments. Its length ranges widely: Human antibodies: Typically, 11–20 amino acids (median 14), forming a near-normal distribution. Bovine antibodies: Feature ultra-long CDR-H3s (>50 residues) with unique "stalk-knob" structures for deep antigen binding. This length diversity expands the antibody repertoire, enabling recognition of structurally diverse antigens, from small molecul...

TB: Time Is Running Out!

Tuberculosis, caused by Mycobacterium tuberculosis , is a severe disease that mainly affects the lungs. TB remains the deadliest killer disease despite the current epidemic of COVID. Like COVID, Tuberculosis bacteria can spread from person to person through sneezing and coughing And post COVID, and the Corona Virus has also posed a risk to people with TB. TB is a potentially fatal disease and has many causes, yet it is preventable and has a wide range of treatments in the market. When the TB affects the lungs, the disease results in being more contagious, with the person usually getting sick and close contact with them can make others affected too. Hence, it also brings isolation and social stigma to the patient suffering from TB. It is mainly considered the disease of the poor as it is prevalent in a more crowded area with fewer resources. TB remains with us in a different form. TB Infection (Latent TB): An individual with TB bacteria in the body who shows no s...

What Is Chimeric Antibody? #chimeric antibody

A chimeric antibody is a type of antibody that is composed of portions from different species of animals. It is created by combining the variable region (which is responsible for binding to specific antigens) of one species' antibody with the constant region (which is responsible for activating the immune system) of another species' antibody. Chimeric antibodies are used in a variety of applications, including cancer treatment and autoimmune disease therapy. They are produced using genetic engineering techniques and are designed to target specific proteins or cells in the body. Blog By Genextgenomics on chimeric antibodies could include information on the different types of chimeric antibodies, their uses and benefits in different medical applications, and the process of producing chimeric antibodies. It could also include case studies or real-world examples of how chimeric antibodies are being used to treat diseases. Other potential topics could include the advantages and l...

GeNext Genomics

Search This Blog